Imatinib 400mg Tablet Altanib

Trade Name: Altanib

Manufacturer: Alkem Laboratories Ltd

Presentation: Tablet

Strength: 400mg

What is the purpose of Imatinib 400mg?

Imatinib 400mg mesylate is licensed to treat Philadelphia chromosome-positive acute lymphoblastic leukemia in adults and children. It’s used in adults to treat recurrent (comeback) or refractory illness (does not respond to treatment).

What is the best way to consume imatinib tablets?

Imatinib is available as a tablet that must be swallowed. It’s usually taken once or twice a day with a full glass of water and a meal. Take imatinib at the same time every day (s). Carefully read and follow the instructions on your prescription labels, and if you have any questions, contact your doctor or pharmacist for clarification.

anything you don’t understand. Is it possible for imatinib to induce bleeding?

GI Bleed and Tear: This medicine has the potential to cause intestinal bleeding or tear. Unexpected bleeding, blood in the stool or black feces, coughing up blood, vomiting blood, vomit that looks like coffee grounds, fever, severe stomach pain, or new abdominal swelling are all symptoms of these disorders.

Is Imatinib 400mg associated with anemia?

  • For people receiving imatinib, the following adverse effects are common (occurring in more than 30% of cases):
  • Blood counts are low.
  • The number of platelets
  • white blood cells,
  • and red blood cells in your blood may temporarily decrease. As a result, you may be more prone to infection, anemia, and/or bleeding. For more details Click Here.

When will I be able to stop taking imatinib?

Patients with chronic myeloid leukemia (CML) who have had the undetectable minimal residual disease (UMRD) for at least two years can safely stop using imatinib (IM). The Stop Imatinib study’s final results are presented.

Is it possible for imatinib to stop working?

To see if your blood counts improve, your doctor may reduce your imatinib dose. Imatinib appears to stop effective in certain patients over time. Imatinib resistance is the term for this. Changes in the genes of CML cells appear to be the source of imatinib resistance.

Imatinib is used to treat a variety of malignancies.

Acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative disorders are among the cancers treated with this drug. This works by preventing or slowing cancer cell multiplication.

If you are looking for another product or brand click here.